These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
310 related articles for article (PubMed ID: 30423460)
1. Human African trypanosomiasis caused by Trypanosoma brucei gambiense: The first case report in China. Chen N; Jin K; Xu J; Zhang J; Weng Y Int J Infect Dis; 2019 Feb; 79():34-36. PubMed ID: 30423460 [TBL] [Abstract][Full Text] [Related]
2. Human African Trypanosomiasis in Emigrant Returning to China from Gabon, 2017. Wang X; Ruan Q; Xu B; Gu J; Qian Y; Chen M; Liu Q; Lu Q; Zhang W Emerg Infect Dis; 2018 Feb; 24(2):400-404. PubMed ID: 29350158 [TBL] [Abstract][Full Text] [Related]
3. Human African trypanosomiasis with 7-year incubation period: clinical, laboratory and neuroimaging findings. Wengert O; Kopp M; Siebert E; Stenzel W; Hegasy G; Suttorp N; Stich A; Zoller T Parasitol Int; 2014 Jun; 63(3):557-60. PubMed ID: 24613272 [TBL] [Abstract][Full Text] [Related]
6. Treatment outcomes and risk factors for relapse in patients with early-stage human African trypanosomiasis (HAT) in the Republic of the Congo. Balasegaram M; Harris S; Checchi F; Hamel C; Karunakara U Bull World Health Organ; 2006 Oct; 84(10):777-82. PubMed ID: 17128357 [TBL] [Abstract][Full Text] [Related]
7. A seven days course of eflornithine for relapsing Trypanosoma brucei gambiense sleeping sickness. Khonde N; Pépin J; Mpia B Trans R Soc Trop Med Hyg; 1997; 91(2):212-3. PubMed ID: 9196773 [TBL] [Abstract][Full Text] [Related]
8. [Congenital human African trypanosomiasis: an observation at the University Hospital of Brazzaville (Congo)]. Oba A; Gahtse A; Ekouya Bowassa G; Nika E; Obengui Arch Pediatr; 2011 Oct; 18(10):1114-5. PubMed ID: 21873039 [No Abstract] [Full Text] [Related]
9. Nifurtimox-eflornithine combination therapy for second-stage Trypanosoma brucei gambiense sleeping sickness: a randomized clinical trial in Congo. Priotto G; Kasparian S; Ngouama D; Ghorashian S; Arnold U; Ghabri S; Karunakara U Clin Infect Dis; 2007 Dec; 45(11):1435-42. PubMed ID: 17990225 [TBL] [Abstract][Full Text] [Related]
10. Gambian trypanosomiasis and synergism between melarsoprol and eflornithine: first case report. Simarro PP; Asumu PN Trans R Soc Trop Med Hyg; 1996; 90(3):315. PubMed ID: 8758090 [No Abstract] [Full Text] [Related]
11. Unusual MRI Findings in African Boukobza M; Lariven S; Houzé S; Laissy JP Am J Trop Med Hyg; 2020 Jan; 102(1):5-6. PubMed ID: 31971136 [No Abstract] [Full Text] [Related]
12. [Psychiatric presentation of human African trypanosomiasis: overview of diagnostic pitfalls, interest of difluoromethylornithine treatment and contribution of magnetic resonance imaging]. Bédat-Millet AL; Charpentier S; Monge-Strauss MF; Woimant F Rev Neurol (Paris); 2000 May; 156(5):505-9. PubMed ID: 10844370 [TBL] [Abstract][Full Text] [Related]
17. Melarsoprol versus eflornithine for treating late-stage Gambian trypanosomiasis in the Republic of the Congo. Balasegaram M; Harris S; Checchi F; Ghorashian S; Hamel C; Karunakara U Bull World Health Organ; 2006 Oct; 84(10):783-91. PubMed ID: 17128358 [TBL] [Abstract][Full Text] [Related]
18. Enantiospecific reassessment of the pharmacokinetics and pharmacodynamics of oral eflornithine against late-stage Trypanosoma brucei gambiense sleeping sickness. Jansson-Löfmark R; Na-Bangchang K; Björkman S; Doua F; Ashton M Antimicrob Agents Chemother; 2015 Feb; 59(2):1299-307. PubMed ID: 25512417 [TBL] [Abstract][Full Text] [Related]
19. A multicentre, randomised, non-inferiority clinical trial comparing a nifurtimox-eflornithine combination to standard eflornithine monotherapy for late stage Trypanosoma brucei gambiense human African trypanosomiasis in Uganda. Kansiime F; Adibaku S; Wamboga C; Idi F; Kato CD; Yamuah L; Vaillant M; Kioy D; Olliaro P; Matovu E Parasit Vectors; 2018 Feb; 11(1):105. PubMed ID: 29471865 [TBL] [Abstract][Full Text] [Related]
20. Skin features accompanying imported human African trypanosomiasis: hemolymphatic Trypanosoma gambiense infection among two French expatriates with dermatologic manifestations. Ezzedine K; Darie H; Le Bras M; Malvy D J Travel Med; 2007; 14(3):192-6. PubMed ID: 17437477 [No Abstract] [Full Text] [Related] [Next] [New Search]